Zhang Bin, Hepner David L, Tran Mary Helen, Friedman Mark, Korn Jonathan R, Menzin Joseph
Boston Health Economics, Inc., 20 Fox Road, Waltham, MA 02451, USA.
Curr Med Res Opin. 2009 Apr;25(4):943-50. doi: 10.1185/03007990902769054.
Reducing operating room (OR) time is of interest to hospital administrators because of high costs of OR utilization. Neuromuscular blocking agents (NMBAs) induce muscle relaxation during surgery. Several acetylcholinesterase inhibitors are used to reverse neuromuscular blockade to shorten recovery time. This study explored the relationship between elapsed OR time and the use of specific NMBAs and reversal agents among patients undergoing selected surgeries based on data from two large hospitals. Specifically, this study sought to test the hypothesis that the application of reversal agents in surgeries using a neuromuscular block would be associated with a decrease in elapsed OR time.
This retrospective cohort study used clinical data from two large hospitals. The authors selected seven types of surgical cases involving thoracic, cardiac, vascular, abdominal, peripheral, urological, and neurological systems. Eligible cases were elective surgeries performed under general anesthesia and using one or more NMBAs (including rocuronium, vecuronium, cisatracurium, and/or pancuronium). Multivariate linear regressions were conducted to examine the relationships among neuromuscular blockade, reversal agent use (including neostigmine, pyridostigmine, and edrophonium), and elapsed OR time by controlling for age, gender, and patient comorbidities.
A total of 9670 surgeries were included in this analysis. The mean elapsed OR time across all surgeries was 227 min, and vecuronium was the most commonly used NMBA. Approximately 67% of all surgeries used a reversal agent. After controlling for confounding factors, use of a reversal agent was shown to be associated with the reduction of elapsed OR time in six of seven types of surgery. The magnitude of this effect ranged from 12 to 46 min of OR time saved. The exception was thoracic surgeries, for which use of a reversal agent was shown to be associated with longer OR time (approximately 26 min). Multivariate regression analyses revealed that the type of NMBA used was also a significant predictor of elapsed time for all surgeries (except cardiac).
This analysis has shown that use of selected neuromuscular blockade reversal agents may lead to more efficient OR resource use.
由于手术室(OR)使用成本高昂,缩短手术室时间受到医院管理人员的关注。神经肌肉阻滞剂(NMBAs)在手术期间诱导肌肉松弛。几种乙酰胆碱酯酶抑制剂用于逆转神经肌肉阻滞以缩短恢复时间。本研究基于两家大型医院的数据,探讨了特定手术患者的手术室时间与特定NMBAs及逆转剂使用之间的关系。具体而言,本研究旨在检验以下假设:在使用神经肌肉阻滞的手术中应用逆转剂将与手术室时间的减少相关。
这项回顾性队列研究使用了两家大型医院的临床数据。作者选择了涉及胸、心、血管、腹、外周、泌尿和神经系统的七种手术病例类型。符合条件的病例为在全身麻醉下进行且使用一种或多种NMBAs(包括罗库溴铵、维库溴铵、顺式阿曲库铵和/或泮库溴铵)的择期手术。通过控制年龄、性别和患者合并症,进行多变量线性回归以检查神经肌肉阻滞、逆转剂使用(包括新斯的明、吡啶斯的明和依酚氯铵)与手术室时间之间的关系。
本分析共纳入9670例手术。所有手术的平均手术室时间为227分钟,维库溴铵是最常用的NMBA。约67%的手术使用了逆转剂。在控制混杂因素后,在七种手术类型中的六种中,使用逆转剂与手术室时间的减少相关。这种效果的幅度为节省12至46分钟的手术室时间。例外情况是胸科手术,使用逆转剂与更长的手术室时间(约26分钟)相关。多变量回归分析显示,所用NMBA的类型也是所有手术(心脏手术除外)时间的重要预测因素。
该分析表明,使用选定的神经肌肉阻滞逆转剂可能会提高手术室资源的使用效率。